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Results: A total of 164 robotic-enhanced PCI procedures were performed by 23
interventional cardiologists in 9 sites. Of these, 60 cases were part of the first 3 cases of
each investigator (roll-ins). There were no differences between the roll-in and later cases
in patient demographics, and clinical and anatomical characteristics. Procedure charac-
teristics and outcomes are summarized in the Table. After the first 3 cases, there were no
additional improvement in experience parameters or outcomes.
Roll-in Cases
n60
Late Cases
n104 P-value
Conversion to manual 0 2 (1.9%) ns
Procedure Duration, min 51.125.5 42.316.4 0.008
PCI duration, min 42.017.5 34.314.1 0.003
Robotic duration, min 28.415.5 22.212.8 0.007
X-ray duration, min 12.87.9 12.24.8 0.009
Contrast volume, ml 138.353.1 147.678.8 ns
Death 0 0
Q-wave MI 0 0
Non-Q MI 2 (3.3%) 2 (1.9%) ns
TVR 0 0
MACE 2 (3.3%) 2 (1.9%) ns
Conclusions: We observed a short learning curve in the performance of robotic-
enhanced PCI in the multi-center PRECISE study. With experience of over 3 cases,
interventional cardiologists were able to complete the robotic-enhanced PCI faster and
with shorter duration of radiation without compromising safety.
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Background: Transapical (TA) access has been increasingly utilized for structural heart
disease interventions and is most commonly obtained under fluoroscopic guidance. However,
a major limitation of fluoroscopy is its ability to provide only 2D projections with inadequate
spatial information. Computed tomographic angiography (CTA)-fluoroscopy fusion can offer
the 3D information necessary for accurate planning and guidance for TA puncture. Although
its utility and safety have been described, the accuracy of TA access by fusion guidance has
not been previously validated.
Methods: We reviewed 15 consecutive patients (mean age 69.111.8 years, 60% male)
presenting to our center from June 2011 to June 2012 who underwent percutaneous left
ventricular (LV) puncture, and subsequent closure, using CTA-fluoroscopy fusion guidance,
and who had post-procedural CTA. We used a prototype software, HeartNavigator (Philips,
Best Netherlands), that allowed for landmark placement on the LV epicardial surface (planned
puncture site-PPS) to guide needle entry. These landmarks were compared to the position of
the TA closure device on the post-procedure CTA (actual puncture site-APS). ImageJ software
(NIH, Bethesda MD) was used to calculate the difference between the PPS and APS. Each
distance measurement was taken in three planes: lateral (X), antero-posterior (Y), and
cranio-caudal (Z). Additional X and Y measurements were also obtained to assess the distance
between the TA access and the left anterior descending artery (LAD).
Results: The mean LV puncture accuracy error in each of the X, Y, and Z planes was
5.654.54 mm, 5.234.66 mm and 8.557.49 mm, respectively. The mean error in
puncture accuracy with respect to the left anterior descending artery (LAD) was 2.89 mm.
Average distance from the APS to the LAD was 30.111.0 mm.
Conclusions: There is significant agreement between the locations of actual and planned
transapical puncture sites using CTA-fluoroscopy fusion guidance. Moreover, fusion imaging
can help maintain an adequate access distance from the LAD. When applied on a larger scale,
fusion imaging can potentially be utilized for safe and accurate transapical access.
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(Rhythmically beating vascular model)
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Background: Percutaneous coronary intervention (PCI) is a well established therapy for
coronary artery disease. However, training methods of PCI has yet to be established.
Methods: We reconstructed the whole body type PCI simulating vascular model from the
imaging data of 64 raw MDCT, including coronary arteries with a significant stenosis. We
combined a heart lung machine into the model and by using the current from the machine
and the drop in negative pressure, while controlling the contraction and dilatation of the
heart block by a sequencer and electromagnetic valve, we were able to make a rhythmical
heart beat. Additionally, by putting the model under water, the X-ray of the silicon was
less visible and thus closer to reality.
Results: We used this Rhythmically beating vascular model at the Kokura Live
demonstration by inserting bifurcation lesions, tortuous lesions and CTO lesions.The
bifurcation model lesion was needed qullotte stenting. The tortuous model lesion was
needed mother and child technique for adequate stent delivery and deployment. The CTO
model lesion was set so with the antegrate approach the wire would enter a sub lumen and
the operator was forced to switch to the retrograde approach. As the current inside the
model was rhythmically beating, we were able to use this model in our usual cath lab and
was not different at all to our usual day to day practices.
Conclusions: This new Rhythmically beating vascular model is more similar to actual
patients and as many kinds of lesions can be made, it is a very adequate training tool for
not only beginners but also advanced cardiologists.
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Background: Interventional endovascular procedures are frequently associated with
complications. The use of endovascular virtual reality simulators allow the training of
procedural complications. Periprocedural complications can be only trained with addi-
tional use of a fullscale patient simulator. Until today no integration of an endovascular
simulator into a fullscale patient simulator has been shown.
Methods: We invented and constructed a totally new fusion of two simulators to put the
idea into action. The hardware of both the endovascular simulator and the patient
simulator was modified. We integrated the endovascular simulator into the body of the
patient simulator. The construction had to fulfill several safety and maintenance issues.
The handling of the newly designed simulator was evaluated by Cardioskills-technicians
and the clinical Cardioskills-Trainer Team that brings multi-year experience in simulator
based trainings with cathlab teams.
Results: We were able to present a fully functioning new fusion of two formerly separate
virtual reality simulators. Procedural and periprocedural complication management could
be trained with high realism with cathlab teams. Initial technical problems of the
implementation could be handled and no compromises had to be accepted.
Conclusions: Simulator based trainings of procedural and periprocedural complications
in the cathlab should be trained with our new simulator set-up instead of the formerly used
simulators alone as we were able to deliver a higher grade of realism and were able to
present technical feasibility.
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MITOS Multimodality Imaging Operating System
Andreas Melzer1, Luc Bidaut1
1University of Dundee, Dundee, United Kingdom
Background: A new Clinical Research Imaging Facility has been established with a
unique combination of the MRI, PET/CT and an interconnecting Interventional Surgical
Suite .
Methods: A novel layout provides access to a MRI suite, PET/CT and further connection
into an interventional suite with standard image guidance. Interventional TAVI /
cardiovascular probes can be placed under MR imaging, and EP ablation performed under
MRI guidance. Alternatively, a procedure that initially starts with MR imaging - e.g., for
planning purposes - may proceed into the ISS or under continued MR guidance to access
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pathology. To refresh the imaging data, patient can be moved from ISS to MC suites, data
acquisition takes place, and the patient is then returned to the ISS where the new MR
imaging data can be used to complete the procedure.
Results: The current set up also permits utilisation of PET in conjunction with ISS
procedures, e.g., as the final imaging modality to control whether PET-enhancing
pathology was completely removed or angioplasty perfoemd. For instance, after comple-
tion of ablation under MR imaging, the patient can be moved into the PET/CT suite. A
PET image produced after tracer injection and uptake can then be used to assess the
completeness of the ablation procedure.
Conclusions: A room layout combining 3T MRI and PET/CT with other interventional
modalities (e.g., fluoroscopy, ultrasound, CT) has been realized for integrated multimo-
dality image-guided diagnosis and therapy of cardiovascular diseases. Such a design
enables corollary studies into novel workflows for taking full advantage of the integrated
design.
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Background: Patient-specific rehearsal (PsR) of an endovascular aortic aneurysm repair
(EVAR) enables the interventionalist to practice the case prior to treat the real patient.
This pilot study aimed to evaluate if PsR for EVAR is feasible, influences technical
performance, to evaluate face validity and the subjective sense of utility.
Methods: Patients with an AAA suitable for EVAR with the Gore C3 Excluder (W.L.
Gore & Assoc, Sunnyvale, California, USA) were enrolled in three centres. A 3D model
of the patient’s anatomy was generated using the PROcedure rehearsal software within the
Angiomentor (Simbionix, Ohio, Cleveland). Less than 24 hours before the real case,
rehearsals were conducted in the Laboratory or Angiosuite. Technical metrics were
recorded. All team members completed a questionnaire evaluating the EVAR experience.
A subjective questionnaire was used to evaluate the realism, technical and human factor
aspects.
Results: Nine patients were enrolled. EVAR procedures were performed by 7 different
teams. 6/8 lead interventionalists were highly experienced in EVAR ( 50 cases). In 7/8
patients, the rehearsal significantly changed the optimal position of the C-arm to
maximally cover the proximal and contralateral landing zones. In 6/8 and 5/8 patients
respectively, an identical oblique or cranio-caudal fluoroscopy angle was chosen in real
life. All team members found the rehearsal useful for selecting the optimal fluoroscopy
angle (median 4, IQR 4-5). The realism of the EVAR procedure simulation was rated
highly (median 4, IQR 3-4). All team members found the PsR useful to optimally prepare
the entire team (median 4, IQR 4-5). The choice of the tool kit (median 2, IQR 1.5-3) nor
the diameter of the device (median 2, IQR 2-3) was likely to be altered by the rehearsal.
Conclusions: PsR for EVAR is feasible and permits creation of realistic case studies.
Subjective evaluation indicates that it may influence optimal C-arm angles, be useful for
preoperative case review and valuable to prepare the entire team. However, a RCT is
required to evaluate how this technology may influence technical and team performance
ultimately leading to improved patient outcomes and increased safety.
Diabetic Patients
Hall D
Tuesday, October 23, 2012, 8:00 AM–10:00 AM
Abstract nos: 337-355
TCT-337
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Background: Diabetes is associated with a higher risk of adverse events following
PCI with drug eluting stents (DES). Within the TWENTE trial, a randomized trial
comparing zotarolimus-eluting Resolute and everolimus-eluting Xience V stents,
a significant interaction was seen between diabetes and DES type with regard to
target vessel failure (TVF). In diabetics, safety and efficacy data of these DES are
scarce.
Methods: In this post-hoc analysis of TWENTE, clinical outcome of both DES in
diabetic (n301; 36.2% insulin-treated) and non-diabetic patients (n1090) was com-
pared. Clinical endpoints were adjudicated by an independent, external events committee.
Multivariate logistic regression analyses were performed to adjust for differences in
baseline variables.
Results: Groups stratified by DES were similar except for a higher prevalence of
hypercholesterolemia in non-diabetic patients of the Xience V arm (p0.04) and calcified
target lesions in diabetic patients of the Resolute arm (p0.04). In both diabetics and
non-diabetic patients, multivariate analysis indicated no significant difference in clinical
outcome between DES. Within non-insulin-treated diabetics, there was also no significant
between-stent difference in clinical outcome. However, in insulin-treated diabetics, the
Resolute arm showed higher rates of target vessel failure (TVF)(28.3% vs 7.3%,
p0.015), target-lesion failure(26.4% vs. 5.5%, p0.016), and patient oriented composite
endpoint(32.1% vs. 10.9%, p0.02). A significant interaction was observed between
insulin treatment and DES type for TVF (p0.029). In Resolute treated patients,
insulin-treated diabetics had a higher rate of TVF compared to non-diabetics and
non-insulin-treated diabetics (p0.001). In the Xience V arm, rates of TVF were similar
across all subgroups.
Conclusions: In non-diabetic patients and non-insulin-treated diabetics, Resolute and
Xience V showed no significant difference in safety and efficacy up to 12 months. In the
limited number of insulin-treated diabetics, Resolute was associated with inferior clinical
outcome. This hypothesis-generating finding requires confirmation in large randomized
trials.
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Meta-analysis of Percutaneous Coronary Intervention Versus Coronary
Artery Bypass Graft Surgery in Patients with Diabetes and Left Main and/or
Multivessel Coronary Artery Disease
Yu Jie Zhou1, Fei Gao2, Zhijian Wang2
1An Zhen Hospital, Capital Medical University, Beijing, China, Beijing, China,
2Anzhen Hospital affiliated with Capital Medical University, Beijing, Beijing
Background: The optimal coronary revascularization strategy for patients with diabetes
and left main and/or multivessel disease is undetermined. The aim of our study was to
evaluate percutaneous coronary intervention (PCI) versus coronary artery bypass graft
(CABG) in those patients.
Methods: We identified 13 articles, published before Oct 2011, enrolling 6992 patients,
follow-up period ranged from 1 to 5 years.
Results: Patients with PCI had a significant reduction in cerebral vascular attack (CVA)
(OR 0.29, 95% CI 0.16 to 0.51, p0.0001, I2 0%) as compared with CABG, whereas
there was a four-fold increased risk of repeat revascularization associated with PCI even
using drug-eluting stent (OR 4.44, 95% CI 3.42 to 5.78, chi2 4.92, p0.00001, I2 0%).
The overall mortality (OR 0.97, 95% CI 0.81 to 1.15, p0.70, I2 0%) was
comparable between the PCI and CABG. However, in subgroup analysis, the
composite outcome (death/myocardial infarction/CVA) was significantly reduced in
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